July 20, 2023 — The ACC Board of Trustees (BOT) has approved the College's newest officers and trustees who will assume their roles in April 2024 following ACC.24 in Atlanta, Ga. 

These new officers, put forth by the ACC Nominating Committee, include: 

July 20, 2023 — The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter randomized controlled clinical trial. This trial aims to evaluate whether a Direct to Angio Suite (DTAS) workflow can improve outcomes for early time-window stroke patients when compared to the conventional method where a diagnostic MR/CT scan is made before transfer to the angio suite.

July 20, 2023 — A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical protocol for cardiovascular computed tomography (CCT) to guide intervention in the right ventricular outflow tract (RVOT) in patients with congenital


July  20, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) is preparing for its 18th Annual Scientific Meeting, SCCT 2023, being held July 27-30 in Boston, MA. Planners with the Arlington, VA-based Society report that the event is designed to engage physicians, trainees, technologists and healthcare professionals in a complete overview of the cardiovascular CT field.
The future is quite promising for TAHs, but it will be a decade or more before they may become a comparable treatment to heart transplantation

The U.S.

July 19, 2023 — The U.S. Food and Drug Administration (FDA) is recommending health care providers, laboratory personnel, and facilities stop using the Quidel Triage Cardiac Panel, manufactured by Quidel Cardiovascular Inc. (QuidelOrtho). 

July 19, 2023 — Ischemic stroke, which occurs when a blood vessel in the brain gets blocked by a clot, is among the leading causes of death worldwide. Fortunately, surgeons now have access to advanced imaging techniques that allow them to visualize the interior of a patient’s brain during a stroke. This helps them pinpoint the location of the clot and analyze the extent of damage to the brain tissue. 

July 19, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients have been successfully treated utilizing Abbott’s EnSite X EP System with 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now